Recent findings suggest a key underlying cause of a common type of stroke has been overlooked for decades, potentially changing diagnosis and treatment approaches.

The CDC has confirmed a parasite outbreak affecting multiple states, prompting health warnings and investigations. Details are still emerging.

Health officials confirm an outbreak of a parasitic infection in North Carolina, with dozens affected. Investigation ongoing to determine source and scope.

Research shows aged muscle stem cells can regain youthful function, but a key challenge remains. This discovery could impact aging and regenerative medicine.

A new spray-on powder has been developed that can halt life-threatening bleeding within one second, promising rapid emergency treatment.

Eyepoint Pharmaceuticals experiences a surge in international coverage, with 25 mentions in recent media monitoring, raising industry interest.

Gavi commits to immunizing an additional 500 million children worldwide despite funding challenges, aiming to strengthen global health efforts.

Gavi’s latest board meeting emphasizes commitment to supporting health sovereignty and addressing fragility in recipient countries.

Gavi allocates $180 million to boost vaccine production capacity across Africa, aiming to improve local immunization efforts and health resilience.

The NHS has launched a new program aimed at enhancing patient services and reducing waiting times, with full implementation expected by early 2024.